STAT
MARCH 17, 2025
Belgian anti-trust regulators are probing Roche over concerns that the drug company took steps to delay the entry of biosimilar versions of two of its cancer medicines. The agency also maintained Roche disseminated “erroneous information” about using biosimilars in combination therapy.
STAT
JULY 5, 2024
WASHINGTON — Pharmaceutical giant AbbVie paid health care providers roughly $145.7 The massive sum spent by AbbVie, the maker of the mega blockbuster anti-inflammatory drug Humira, is the most a pharmaceutical company has spent on marketing to doctors since such data became available in 2017.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
OCTOBER 10, 2024
Separately, the drugmaker agreed to pay $25 million to settle charges of participating in a price-fixing scheme with other generic companies. At the same time, Teva steadily raised the price of its drug by thousands of dollars. At the same time, Teva steadily raised the price of its drug by thousands of dollars.
STAT
FEBRUARY 29, 2024
As pharma companies wrestle with how and when to use wearables and other digital technologies to measure how their experimental drugs impact patients, clinical research giant Icon has acquired HumanFirst, which helps companies answer exactly those sorts of questions.
STAT
MAY 11, 2023
Thanks to changes in tax law six years ago, several of the largest pharmaceutical companies saw their tax rates fall substantially, but they also reported that most of their profits were shifted offshore in an effort to avoid paying U.S. In 2017, a new law was passed that permanently lowered corporate tax rates from 35% to 21%.
European Pharmaceutical Review
OCTOBER 24, 2022
The number of industry clinical trials initiated in the UK, per year, fell by 41 percent from 2017 to 2021, according to the latest annual report on clinical research from the Association of the British Pharmaceutical Industry ( ABPI ). million people living with rare diseases in the UK.
STAT
JULY 8, 2024
The massive sum spent by the company, which makes the blockbuster Humira anti-inflammatory drug, is the most a pharmaceutical company has doled out on marketing to doctors since such data became available in 2017. AbbVie paid health care providers roughly $145.7
Expert insights. Personalized for you.
226 
Let's personalize your content